clinical trials

Racing rising resistance, Novartis marches malaria therapy into phase 3
Fierce Biotech
Wed, 11/23/22 - 07:55 am
Novartis
malaria
Medicines for Malaria
clinical trials
ganaplacide
Merck scores another win for Keytruda, this time in HER2-negative cancer
Endpoints
Tue, 11/22/22 - 04:39 pm
Merck
Keytruda
clinical trials
adenocarcinoma
GSK to pull blood cancer drug from US market after study failure
BioPharma Dive
Tue, 11/22/22 - 11:08 am
GSK
blood cancer
Blenrep
clinical trials
Multiple Myeloma
Pfizer's $1B protein degradation bet yields 3% response rate in Arvinas' midphase breast cancer trial
Fierce Biotech
Tue, 11/22/22 - 11:00 am
Pfizer
protein degradation
Arvinas
clinical trials
breast cancer
ARV-471
Novo Nordisk invests $74M to boost API manufacturing for clinical trials
Fierce Biotech
Tue, 11/22/22 - 10:52 am
Novo Nordisk
clinical trials
APIs
API manufacturing
R&D
NW Bio reports positive top-line results from phase 3 glioblastoma trial
Labiotech.eu
Mon, 11/21/22 - 07:23 pm
Northwest Biotherapeutics
DCVax
clinical trials
glioblastoma
brain cancer
vaccines
Lysogene's lead gene therapy flunks phase 2/3 trial almost a year after Sarepta walked out
Fierce Biotech
Sun, 11/20/22 - 12:54 pm
Lysogene
gene therapy
clinical trials
LYS-SAF302
Sanfillipo Syndrome
Kinevant doses first patient in Phase II pulmonary sarcoidosis trial
Clinical Trials Arena
Sun, 11/20/22 - 12:49 pm
Kinevant
clinical trials
pulmonary sarcoidosis
namilumab
Kidney Therapeutics to Halt CKD Progression, Make Late-Stage Push Toward NDA
BioSpace
Fri, 11/18/22 - 11:40 am
Kidney Therapeutics
chronic kidney disease
clinical trials
Arcutis boasts positive data for topical Phase III candidate Roflumilast
Clinical Trials Arena
Fri, 11/18/22 - 11:36 am
Arcutis Biotherapeutics
roflumilast
clinical trials
After FDA setback, MEI, Kyowa confirm phase 2 efficacy with Japanese blood cancer data drop
Fierce Biotech
Fri, 11/18/22 - 10:45 am
Kyowa Kirin
MEI Pharma
zandelisib
clinical trials
non-Hodgkin lymphoma
Takeda touts positive first-line leukemia results — but isn't quite ready to reveal the hard data
Endpoints
Thu, 11/17/22 - 11:36 pm
Takeda
Ariad Pharmaceuticals
Iclusig
clinical trials
acute lymphoblastic leukemia
Pfizer, BioNTech start study testing next COVID-19 vaccine
BioPharma Dive
Thu, 11/17/22 - 11:25 pm
Pfizer
BioNTech
vaccines
COVID-19
clinical trials
Editas halts lead CRISPR program after efficacy data underwhelm
Endpoints
Thu, 11/17/22 - 12:10 pm
Editas Medicine
CRISPR
EDIT-101
clinical trials
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Fierce Biotech
Thu, 11/17/22 - 10:37 am
Astellas
zolbetuximab
clinical trials
cancer
gastric cancer
AstraZeneca Launches Phase II Trial of Anti-TIGIT NSCLC Therapy
BioSpace
Wed, 11/16/22 - 11:24 pm
AstraZeneca
clinical trials
non-small lung cancer
AZD2936
Novartis halts phase 1 cancer trial of CD73 antagonist over efficacy, but combo studies continue
Fierce Biotech
Wed, 11/16/22 - 10:40 am
Novartis
clinical trials
NZV930
One down, one to go: Arcutis' repurposed AstraZeneca drug clears first PhIII eczema trial
Endpoints
Tue, 11/15/22 - 06:35 pm
Arcutis Biotherapeutics
eczema
clinical trials
roflumilast
Lumos' oral growth hormone drug falls short of Novo's injectable incumbent at interim analysis
Fierce Pharma
Tue, 11/15/22 - 11:06 am
Lumos Pharma
growth hormone
Novo Nordisk
clinical trials
Daiichi Sankyo’s Covid-19 vaccine trial meets primary endpoint
Clinical Trials Arena
Tue, 11/15/22 - 10:51 am
Daiichi Sankyo
clinical trials
MRNA
vaccines
DS-5670
COVID-19

Pages